Claravis 40 MG capsule 10S
Ended Awarded Last action
- Contract number
- SPE2DR26F94G3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,678
Award facts
- Contract value 100% obligated
- $11,677.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded December 1, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, authorizes the supply of Claravis 40 mg capsules (a vitamin A derivative used for severe acne treatment) with a ceiling value of $11,677.81 and ultimate completion date of December 2, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. Through this vehicle, AmerisourceBergen supplies the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with critical pharmaceutical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F94G3?
SPE2DR26F94G3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26F94G3 worth?
The government has obligated $11,678 on SPE2DR26F94G3.
Is contract SPE2DR26F94G3 an order under another contract?
Yes. SPE2DR26F94G3 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F94G3 competed?
The extent of competition for SPE2DR26F94G3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award